Data / Form D filings / Personal Genome Diagnostics Inc.
Personal Genome Diagnostics Inc.: Form D filings
Personal Genome Diagnostics Inc., a biotechnology company in Baltimore, MD, filed 8 Form D notices with the SEC between 2011 and 2021. The latest, on February 23, 2021, reports $97.7 million sold of a $98.3 million offering to 38 investors.
Find out what Personal Genome Diagnostics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2809 BOSTON STREET, SUITE 503, Baltimore, MD, 21224
- Phone
- (443) 602-8833
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1530958
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 23, 2021 | New notice | $98,295,724 | $97,729,418 | $566,306 | 38 | Feb 5, 2021 | sec.gov |
| May 26, 2020 | New notice | $3,550,000 | $2,750,000 | $800,000 | 2 | May 9, 2020 | sec.gov |
| Jun 24, 2019 | New notice | $20,000,000 | $5,000,000 | $15,000,000 | 1 | Jun 7, 2019 | sec.gov |
| Oct 30, 2017 | New notice | $111,517,424 | $65,367,412 | $46,150,012 | 12 | Oct 13, 2017 | sec.gov |
| Nov 6, 2015 | New notice | $21,445,808 | $20,451,998 | $993,810 | 22 | Oct 23, 2015 | sec.gov |
| Jun 3, 2015 | New notice | Indefinite | $4,322,000 | Indefinite | 18 | May 20, 2015 | sec.gov |
| Mar 17, 2014 | New notice | $3,500,000 | $2,000,000 | $1,500,000 | 2 | Mar 7, 2014 | sec.gov |
| Sep 23, 2011 | New notice | $500,000 | $500,000 | $0 | 1 | Aug 31, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Luis A. Diaz, Jr. | Director | |
| Victor A. Velculescu | Director | |
| Justin A. Klein | Director | |
| Megan A. Bailey | Executive Officer, Director | |
| Kavita A. Patel | Director | |
| James A. LaFrance | Director | |
| Scott A. Gotshall | Executive Officer | |
| Samuel A. Anguioli | Executive Officer | |
| Lily A. Li | Director | |
| Jack A. Crowley | Executive Officer | |
| Kevin A. Reidy | Director |
Other biotechnology companies in Maryland that filed recently
- BlueHealer Inc. $1 · Nov 4, 2026
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
- Uvantis Therapeutics, Inc. $100,000 · Sep 23, 2026
- Gliknik Inc $15 million · Sep 17, 2026
- Georgiamune, Inc. $92.7 million · Aug 17, 2026
Every Form D from the week of Feb 22, 2021 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Personal Genome Diagnostics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.